What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?
Your search for major depressive disorder returned 19 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers sought to assess the impact of early vs late initiation of natalizumab by looking at clinical and imaging information of patients with MS.
In a retrospective study, researchers determined whether the COVID-19 pandemic and COVID-19 infection affects disease course in patients with MS.
In a prospective cohort study, researchers assessed whether adverse childhood experiences may increase the risk for multiple sclerosis in women.
Researchers sought understand the genetic predisposition and environmental factors on monozygotic twin pairs discordant for MS.
Investigators conducted a survey to assess the incidence of COVID-19 in patients with multiple sclerosis as well as the influence of their comorbidities and treatments on outcomes.
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
Awareness of urinary tract infection among individuals with multiple sclerosis is critical in diagnosis, management, and prophylaxis in this population.
Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.
Disease course, fatigue, self-efficacy, and diet and exercise are major determinants of unemployment for patients with MS.
Research highlights the need for healthcare professionals to proactively and directly address the issues and risks of DMTs in terms of MS patients’ family planning activities.
Investigators analyzed the clinical, psychological, and cognitive factors that affect perceived and cognitive performance fatigability in patients with multiple sclerosis.
Polyneuropathies occurring in multiple sclerosis contribute to neurological disability.
First symptoms and disease type are contributors to delays in multiple sclerosis diagnosis.
Investigators examine the role of physical activity and exercise in the modification of vascular comorbidities and risk factors in individuals with multiple sclerosis.
The impact of treatment with dimethyl fumarate and fingolimod on lymphocyte and leukocyte count was evaluated in patients with multiple sclerosis.
When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.
More robust studies suggest that the prevalence of olfactory dysfunction is significant, ranging from 20% to 45% in the MS population.
Hippocampal DVR was strongly correlated with the Beck’s Depression Inventory score in patients with MS.
Latest News Your top articles for MondayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses